The acquisition significantly expands Marvell's AI connectivity portfolio and TAM to $550 billion, with expected EPS accretion and $1B+ in synergies. Key risks include regulatory approval, integration execution, and potential dilution from the all-stock consideration. Monitor stockholder votes and regulatory milestones through 1H CY28.
How the stock moved after the report
⚠ Clustered BULLISH VIEWSTOCK BELOW ENTRY AT T+5- T+0 · Nov 2 $171.41entry
- T+1 · 14d ago +0.33%α +0.03% · $171.97
- T+5 · 8d ago −9.81%α −9.89% · $154.60
- T+10 · todayOpen
- T+20 · in 14d Pending
- T+60 · in 2mo Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Marvell announced a definitive agreement to acquire Lumentum in an all-stock transaction valued at an implied enterprise value of $115 billion for Lumentum, combining Marvell's electrical and optical interconnect with Lumentum's photonics to create an AI connectivity leader. The deal is expected to close in the first half of calendar year 2028, be accretive to Marvell non-GAAP EPS in year one post-close, and deliver over $1 billion in annual run-rate cost synergies. Marvell also narrowed its fiscal Q3 2027 preliminary revenue guidance range to plus or minus 2% from plus or minus 5%, maintaining the midpoint.
Key Financial Metrics
Key Facts
- Marvell to acquire Lumentum in an all-stock transaction with a fixed exchange ratio of 4.500 Marvell shares per Lumentum share.
- Implied enterprise value of $115 billion for Lumentum, representing a premium of approximately 23.9% based on unaffected closing prices as of October 28, 2026.
- Pro forma ownership: ~67% Marvell stockholders, ~33% Lumentum stockholders on a fully diluted basis.
- Transaction expected to close in the first half of calendar year 2028, subject to stockholder and regulatory approvals.
- Expected to be accretive to Marvell non-GAAP EPS in year one post-close, with line of sight to more than $1 billion in annual run-rate cost synergies, primarily COGS.
- Combined company's total addressable market expected to expand to $550 billion.
- Marvell reported preliminary revenue for fiscal Q3 2027 consistent with prior guidance midpoint, narrowing the expected range to plus or minus 2% from plus or minus 5%.
- Matt Murphy to remain Chairman and CEO of the combined company; three Lumentum directors, including CEO Michael Hurlston, to join Marvell's Board.
Financial Impact
Acquisition of Lumentum at an implied enterprise value of $115 billion; combined pro forma annualized revenue of approximately $17.7 billion (Marvell $12.6B, Lumentum $5.1B); over $1 billion in annual run-rate cost synergies expected.
Risk Factors
- Regulatory approval risks, including potential antitrust or national security reviews.
- Integration risk given the size and complexity of combining two large semiconductor companies.
- Dilution to Marvell stockholders from issuing shares representing approximately 33% of the combined company.
- Execution risk in achieving $1 billion+ in annual run-rate cost synergies and margin expansion targets.
- Preliminary revenue guidance for fiscal Q3 2027 is unaudited and subject to completion of quarter-end closing procedures.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 7 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-442714 |
| Document: d81187dex991.htm | 0001193125-26-442714 |
| Document: d81187dex992.htm | 0001193125-26-442714 |
| Document: 0001193125-26-442714-index-headers.html | 0001193125-26-442714 |
| Document: 0001193125-26-442714-index.html | 0001193125-26-442714 |
| Document: 0001193125-26-442714.txt | 0001193125-26-442714 |
| 8-K Data (Synthetic) | 0001193125-26-442714 |
Track record
49 reports on MRVL
10 of 14 bullish or bearish reports moved the stock their way by T+1. Best: +145.40% at T+60 after the Mar 5, 2026 report. 13 of 14 went positive at some point.
Filters
- Nov 13, 20263d ago 3 Neutral 2/10 Entry $156.76 to $145.36 Now $145.36 −7.27% ▼ −7.27% −5.36% vs SPY
- Nov 13, 20263d ago 3 Neutral 2/10 Entry $156.76 to $145.36 Now $145.36 −7.27% ▼ −7.27% −5.36% vs SPY
- Nov 13, 20263d ago 3 Neutral 1/10 Entry $156.76 to $145.36 Now $145.36 −7.27% ▼ −7.27% −5.36% vs SPY
- Nov 12, 20264d ago 8-K Neutral 2/10 Entry $164.45 to $156.76 Now $145.36 −11.61% ▼ −4.68% −4.31% vs SPY
- Nov 5, 202611d ago SC 13G/A Neutral 2/10 Entry $133.55 to $141.20 Now $145.36 +8.84% ▲ +5.73% +5.42% vs SPY
- Nov 3, 202613d ago ANALYST-DOWNGRADE Bearish 6/10 Entry $171.97 to $159.80 Now $145.36 +15.47% ▲ +7.08% +8.73% vs SPY
- Nov 3, 202613d ago ANALYST-DOWNGRADE Bearish 5/10 Entry $171.97 to $159.80 Now $145.36 +15.47% ▲ +7.08% +8.73% vs SPY
- Nov 2, 202614d ago 144 Neutral 2/10 Entry $171.97 to $159.80 Now $145.36 −15.47% ▼ −7.08% −8.73% vs SPY
- Nov 2, 202614d ago 425 Mixed 7/10 Entry $171.41 to $171.97 Now $145.36 −15.20% ▲ +0.33% +0.03% vs SPY
- Nov 2, 202614d ago 425 Mixed 7/10 Entry $171.41 to $171.97 Now $145.36 −15.20% ▲ +0.33% +0.03% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers